LAUREN CANO: Open Payments
NPI 1912395310 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$823 in 37 payments from 18 companies in 2025. Trend: 2023 $674 · 2024 $1,231 · 2025 $823
Food & beverage: $823
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $103 |
| Novo Nordisk Inc | 5 | $100 |
| Lilly USA, LLC | 4 | $89 |
| PFIZER INC. | 3 | $66 |
| Amgen Inc. | 4 | $63 |
| Dexcom, Inc. | 2 | $52 |
| Abbott Laboratories | 2 | $47 |
| Inspire Medical Systems, Inc. | 2 | $44 |
| Antares Pharma, Inc. | 2 | $37 |
| ABBVIE INC. | 1 | $30 |
Products named: LEQVIO, MOUNJARO, EVENITY, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, JARDIANCE, INSPIRE, ELIQUIS.
Industry payments across MD — which companies pay providers there.
